Pharmafile Logo
Pharmafocus logo
Advanced Search

Deloitte

Showing 8 posts of 8 posts found.

Vital Signs: Partnerships between industry, providers and academia

February 10, 2017
Medical Communications Deloitte

Hanno Ronte, life sciences partner at Deloitte, writes upon the opportunities available when a collaborative environment between industry, providers and …

News
mr

Innovative routes to market: Rethinking the life sciences distribution model

January 27, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Deloitte, distribution

Originally published in the latest issue of Pharmafile, Deloitte’s life sciences director Lee Feander discusses the often-undervalued importance of distribution …

News
Ian Goldin, director, Oxford Martin School, University of Oxford speaks at the c

Visions for the future: FT pharma and biotech event

December 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, ABPI, Deloitte, Medidata, Whitehead, financial ties, freeman, ft pharma

The FT Global Pharmaceutical and Biotechnology Conference held in London recently asked: “What will the life science company of the …

Feature
scott_evangelista_quintiles

Quintiles hires head from Deloitte

December 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deloitte, Quintiles

Contract research organisation Quintiles has appointed Scott Evangelista as its president for Integrated Commercial Services and Solutions.  The firm said …

Appointment
research image

Report: ‘R&D isn’t paying’

December 3, 2013
Research and Development, Sales and Marketing Deloitte, R&D, pharma, research and development, reuters

On average, the world’s biggest pharma companies are not getting enough of a return out of their R&D efforts, according …

News

Big pharma counts cost of R&D decline

November 23, 2011
Research and Development Deloitte, GSK, IIR, R&D productivity

Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …

News
Blog footer

Digital Pharma: Industry still cautious about social media

December 23, 2010
Medical Communications Deloitte, Digital Pharma blog, doctors' social networks, social media, social networking

Life sciences companies remain cautious about using social networks, such as the healthcare professional community Sermo, largely because of a …

News

Deloitte boosts Life Sciences & Health Care practice

February 12, 2010
Sales and Marketing Deloitte, appointment, sales and marketing

Business advisory firm Deloitte has made three senior appointments to its UK Life Sciences & Health Care practice. Julian Remnant …

Appointment

Latest content

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023

Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment

December 6, 2023

British Medical Journal publishes letter calling on government to reduce rate of antidepressant prescribing

December 5, 2023

Genentech shares positive results from phase 3 trial for breast cancer treatment

December 5, 2023

Dr Stefano Gulià appointed as chief scientific officer of Kling Bio

December 5, 2023